Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis

Pulmonary hypertension (PH) complicating chronic obstructive pulmonary disease (COPD-PH) and interstitial lung disease (ILD-PH) (World Health Organization [WHO] Group III PH) increases medical costs and reduces survival. Despite limited data, many clinicians are using pulmonary arterial hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Kurt W., Duval, Sue, Markowitz, Jeremy, Pritzker, Marc, Thenappan, Thenappan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448533/
https://www.ncbi.nlm.nih.gov/pubmed/28680574
http://dx.doi.org/10.1086/690017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448533/
https://www.ncbi.nlm.nih.gov/pubmed/28680574
http://dx.doi.org/10.1086/690017

Ejemplares similares